NASDAQ: ARTL
Artelo Biosciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for ARTL

Based on 2 analysts offering 12 month price targets for Artelo Biosciences Inc

Min Forecast
$30.00+316.96%
Avg Forecast
$33.00+358.65%
Max Forecast
$36.00+400.35%

Should I buy or sell ARTL stock?

Based on 2 analysts offering ratings for Artelo Biosciences Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ARTL stock forecasts and price targets.

ARTL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-06-06
lockedlocked$00.00+00.00%2025-03-04

1 of 1

Forecast return on equity

Is ARTL forecast to generate an efficient return?

Company
N/A
Industry
83.55%
Market
67.39%

Forecast return on assets

Is ARTL forecast to generate an efficient return on assets?

Company
N/A
Industry
22.55%

ARTL earnings per share forecast

What is ARTL's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$11.04

ARTL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ARTL$7.20$33.00+358.65%Strong Buy
TOVX$0.48N/AN/A
EVAX$2.77$10.00+261.01%Strong Buy
VRAX$0.88$3.00+240.14%Buy
TTNP$4.45N/AN/A

Artelo Biosciences Stock Forecast FAQ

Is Artelo Biosciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ARTL) stock is to Strong Buy ARTL stock.

Out of 2 analysts, 1 (50%) are recommending ARTL as a Strong Buy, 1 (50%) are recommending ARTL as a Buy, 0 (0%) are recommending ARTL as a Hold, 0 (0%) are recommending ARTL as a Sell, and 0 (0%) are recommending ARTL as a Strong Sell.

If you're new to stock investing, here's how to buy Artelo Biosciences stock.

What is ARTL's earnings growth forecast for 2025-2025?

(NASDAQ: ARTL) Artelo Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.43%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.71%.

Artelo Biosciences's earnings in 2025 is -$9,715,000.

In 2025, ARTL is forecast to generate -$6,035,900 in earnings, with the lowest earnings forecast at -$6,035,900 and the highest earnings forecast at -$6,035,900.

What is ARTL's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: ARTL) forecast ROE is N/A, which is considered weak.

What is ARTL's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ARTL price target, the average ARTL price target is $33.00, with the highest ARTL stock price forecast at $36.00 and the lowest ARTL stock price forecast at $30.00.

On average, Wall Street analysts predict that Artelo Biosciences's share price could reach $33.00 by Jun 6, 2026. The average Artelo Biosciences stock price prediction forecasts a potential upside of 358.65% from the current ARTL share price of $7.20.

What is ARTL's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: ARTL) Artelo Biosciences's current Earnings Per Share (EPS) is -$17.94. In 2025, ARTL's EPS is forecast to hit -$11.04 (min: -$11.04, max: -$11.04).

What is ARTL's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: ARTL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 22.55%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.